Tags

Type your tag names separated by a space and hit enter

Failure of oral bromocriptine to affect hypergastrinemia in two patients with the Zollinger-Ellison syndrome.
J Endocrinol Invest. 1978 Oct; 1(4):351-3.JE

Abstract

Bromocriptine was administered to 2 subjects with gastrin-secreting tumors of the pancreas. The absorption of the drug was confirmed by a rise in growth hormone levels but no change in the elevated serum gastrin levels were observed. Bromocriptine does not appear to affect gastrin hypersecretion in the way that it influences the hypersecretion of pituitary hormones.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

229152

Citation

Child, D F., et al. "Failure of Oral Bromocriptine to Affect Hypergastrinemia in Two Patients With the Zollinger-Ellison Syndrome." Journal of Endocrinological Investigation, vol. 1, no. 4, 1978, pp. 351-3.
Child DF, Laing I, Ganguli PC. Failure of oral bromocriptine to affect hypergastrinemia in two patients with the Zollinger-Ellison syndrome. J Endocrinol Invest. 1978;1(4):351-3.
Child, D. F., Laing, I., & Ganguli, P. C. (1978). Failure of oral bromocriptine to affect hypergastrinemia in two patients with the Zollinger-Ellison syndrome. Journal of Endocrinological Investigation, 1(4), 351-3.
Child DF, Laing I, Ganguli PC. Failure of Oral Bromocriptine to Affect Hypergastrinemia in Two Patients With the Zollinger-Ellison Syndrome. J Endocrinol Invest. 1978;1(4):351-3. PubMed PMID: 229152.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Failure of oral bromocriptine to affect hypergastrinemia in two patients with the Zollinger-Ellison syndrome. AU - Child,D F, AU - Laing,I, AU - Ganguli,P C, PY - 1978/10/1/pubmed PY - 1978/10/1/medline PY - 1978/10/1/entrez SP - 351 EP - 3 JF - Journal of endocrinological investigation JO - J Endocrinol Invest VL - 1 IS - 4 N2 - Bromocriptine was administered to 2 subjects with gastrin-secreting tumors of the pancreas. The absorption of the drug was confirmed by a rise in growth hormone levels but no change in the elevated serum gastrin levels were observed. Bromocriptine does not appear to affect gastrin hypersecretion in the way that it influences the hypersecretion of pituitary hormones. SN - 0391-4097 UR - https://www.unboundmedicine.com/medline/citation/229152/Failure_of_oral_bromocriptine_to_affect_hypergastrinemia_in_two_patients_with_the_Zollinger_Ellison_syndrome_ L2 - https://link.springer.com/article/10.1007/BF03350981 DB - PRIME DP - Unbound Medicine ER -